Orchard Software and CDR Laboratories have partnered to rapidly implement monkeypox testing. According to the Centers for Disease Control and Prevention, the number of Monkeypox (Orthopoxvirus) cases are on the rise. To mitigate the virus’ spread, laboratories must quickly identify the virus and communicate results so that timely treatment and contact tracing can take place.
Miami-based CDR Laboratories is a CLIA and CAP life science laboratory that specializes in molecular diagnostics with a focus on speed of results reporting to enable faster patient care. CDR Labs also provides chemistry, toxicology, and hematology testing. Its collaboration with Orchard enables rapid reporting and response to monkeypox virus test results.
“CDR Labs is proud to respond to the public health emergency to provide a safe, accurate test for identification of Monkeypox,” said Sarah M.J. Helber, PhD, HCLD (ABB), Chief Laboratory Officer for CDR Labs. “Our goal is to provide efficient collection and rapid turnaround times for all our patients to curb the spread of this disease. As the first laboratory to collaborate with Orchard on implementing monkeypox testing, I was pleased with how rapidly Orchard was able to configure our LIS to process and report monkeypox results.”
“We are excited to partner with CDR Laboratories to facilitate rapid reporting of Monkeypox virus results to help address this public health emergency,” said Billie Whitehurst, CEO of Orchard Software. “Our innovative solution provides laboratories with ordering and reporting tools that allow them to play an active part in addressing infectious disease threats.”